Drugmakers Can't Appeal Remand of Darvocet Suits: 6th Circ.
The Sixth Circuit on Tuesday said Endo Pharmaceuticals and others cannot appeal a Kentucky federal judge's recommendation to remand cases alleging they failed to warn customers of risks associated with Darvocet...To view the full article, register now.
Already a subscriber? Click here to view full article